cgp 361a has been researched along with flupenthixol in 1 studies
| Studies (cgp 361a) | Trials (cgp 361a) | Recent Studies (post-2010) (cgp 361a) | Studies (flupenthixol) | Trials (flupenthixol) | Recent Studies (post-2010) (flupenthixol) |
|---|---|---|---|---|---|
| 21 | 3 | 3 | 929 | 128 | 138 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allerup, P; Bech, P; Bjerrum, H; Jakobsen, K; Thunedborg, K | 1 |
1 trial(s) available for cgp 361a and flupenthixol
| Article | Year |
|---|---|
Treatment of generalized anxiety disorder: comparison of a new beta-blocking drug (CGP 361 A), low-dose neuroleptic (flupenthixol), and placebo.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Propanolamines; Psychiatric Status Rating Scales | 1992 |